mitoXANTRONE Injection USP (concentrate), 20 mg/10 mL (2 mg/mL), 10 mL Multiple Dose Vial packaged in a carton, Rx only, Teva Parenteral Medicines, Inc., Irvine, CA 92618, NDC 0703-4685-01.
Published August 3, 2016 · Recall initiated: May 31, 2016
Summary
FDA records drug Class III recall D-1451-2016, published August 3, 2016 and initiated May 31, 2016. Recalling firm: Teva North America; Status: Terminated; Reported quantity: 2,506 vials; Lot: Lot # 31318659B, Exp 02/17. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specifications: High out of specification results for Impurity D.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Teva North America
- Distributor
- Nationwide
- Lot
- Lot # 31318659B, Exp 02/17
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAClaravis (isotretinoin capsules USP), 10mg, packaged in carton containing 3 Blister Packs of 10 Capsules EachOctober 12, 2016
- FDALinezolid Injection 600 mg/300 mL Rx Only, Manufactured in Hungary for TEVA PHARMACEUTICALS USA, INC., NorthSeptember 14, 2016
- FDAARGATROBAN Injection in 0.9% Sodium Chloride 250 mg/250 mL (1 mg/mL) , Rx Only, Manufactured in Hungary forSeptember 14, 2016
- FDAEptifibatide Injection 75 mg/100 mL (0.75 mg/mL) single use vial, For Intravenous Use Only, Rx Only,September 14, 2016
- FDAOxacillin for Injection, USP, 10 grams per pharmacy bulk package, Buffered - For IV Use, Sterile,August 3, 2016
- FDABroccoli & Cauliflower, brand Wild Oats Organic, frozen, net wt. 10 oz., UPC 4873700711 The ingredientsAugust 3, 2016
Questions about this recall
Was mitoXANTRONE Injection USP (concentrate), 20 mg/10 mL (2 mg/mL), 10 mL Multiple Dose Vial packaged in a carton, Rx only, Teva Parenteral Medicines, Inc., Irvine, CA 92618, NDC 0703-4685-01. recalled?
Yes. FDA published recall D-1451-2016 on August 3, 2016. Reported hazard: Failed Impurities/Degradation Specifications: High out of specification results for Impurity D.
What should I do if I have this product?
Voluntary: Firm initiated · Letter